In clinical practice, Tirzepatide often leads to greater weight loss, which can be a deciding factor for individuals focused primarily on losing weight
One major disadvantage of peptides is their limited stability in biological systems
If you feel hungrier and eat more than usual, it could reduce the effectiveness of Semaglutide in helping you manage your weight
Recent research suggests pleiotropic therapeutic endpoints, such as the lowered risk of cardiovascular complications in vulnerable populations [1, 2]
These may include nausea, vomiting, diarrhea, and constipation
Tirzepatide users may experience slightly higher rates of nausea due to its dual-action mechanism, though this varies widely among individuals